HomeNews

News

Breaking Down the Affect of SERENA-6 for Some With Breast Most cancers

Dr. Julia E. McGuinness and Dr. Joshua Okay. Sabari talk about the SERENA-6 trial and its outcomes for sufferers with ESR1-mutated HR+/HER2— breast most...

FDA Updates Talzenna-Xtandi Label for HRR-Mutated Metastatic Prostate Most cancers

FDA approves up to date labeling for Talzenna plus Xtandi in males with HRR gene-mutated metastatic prostate most cancers: © inventory.adobe.com.The U.S. Meals...

Why I Don’t Name Myself a Survivor With Metastatic Breast Most cancers

I can nonetheless clearly bear in mind individuals’s reactions after I completed chemo for the primary time in 2014, a couple of months...

Why is Medical Trial Enrollment Essential for These With Kidney Most cancers?

Sufferers with kidney most cancers might profit from scientific trial enrollment, as Dr. Michael Serzan defined whereas discussing early outcomes from the STELLAR-002...

Exploring Palliative and Healing Radiation for Lung Most cancers

Radiation for lung most cancers is usually given in considered one of two settings: to alleviate signs or with healing intent for unresectable...

Hot Topics